Mortality in Parkinson's disease: A systematic review and meta‐analysis

Macleod, Angus D., Taylor, Kate S.M., Counsell, Carl E.·2014·Movement Disorders
DOI 10.1002/mds.25898

Cited by (331)

Items 201–300 of 331

  1. [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis
    Lars Frings, Franziska Henninger, Martin Treppner, Göran Köber, Martin Boeker, Sabine Hellwig, Ralph Buchert, Philipp Tobias Meyer · 2020 · Journal of Parkinson s Disease
  2. Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic
    Mickael Aubignat · 2021 · Revue Neurologique
  3. Salience Network And Cognitive Impairment in Parkinson's Disease
    Brooke E. Yeager, Hunter P Twedt, Joel Bruss, Jordan L. Schultz, Nandakumar S. Narayanan · 2023 · medRxiv
  4. All-Cause and Cause-Specific Mortality in Parkinson’s Disease: A Meta-Analysis
    Young Ho Lee, Gwan Gyu Song · 2025 · Neuroepidemiology
  5. Refining the diagnostic accuracy of Parkinsonian disorders using metaphenomic annotation of the clinicopathological literature
    Quin Massey, Leonidas Nihoyannopoulos, Peter Zeidman, Thomas T. Warner, Kailash P. Bhatia, Sonia Gandhi, Christian Lambert · 2025 · npj Parkinson s Disease
  6. Long-Term Mortality and 10-Year Outcomes after Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease
    Hikaru Kamo, Genko Oyama, Mai Shimizu, Masanobu Ito, Hirokazu Iwamuro, Atsushi Umemura, Taku Hatano, Nobutaka Hattori · 2026 · Stereotactic and Functional Neurosurgery
  7. DOENÇA DE PARKINSON: SENTIMENTOS ATRIBUÍDOS AO CONVÍVIO À LUZ DO CUIDADOR FAMILIAR
    Rogério Donizeti Reis, Ewerton Naves Dias, Marcos Antônio Batista, Marcos Mesquita Filho, José Vitor da Silva · 2019 · Estudos Interdisciplinares sobre o Envelhecimento
  8. The dilemma between milestones of progression versus clinical scales in Parkinson's disease
    Julia C. Greenland, Marta Camacho, Caroline H. Williams‐Gray · 2023 · Handbook of clinical neurology
  9. 25-year trends in first-time hospitalizations for Parkinson's disease and subsequent mortality: A Danish nationwide cohort study
    Merete Osler, G.T. Okholm, Terese Sara Høj Jørgensen, Maarten Pieter Rozing · 2023 · Parkinsonism & Related Disorders
  10. The Association between Parkinson’s Disease and Congestive Heart Failure in Korea: A Nationwide Longitudinal Cohort Study
    Jimin Kim, Hakyung Kim, Sol Bi Kim, Woo Yup Kim, Seung Hun Sheen, Inbo Han, Je Beom Hong, Seil Sohn · 2023 · Journal of Personalized Medicine
  11. Exercise Strategies for Parkinson Disease Management
    Spencer Ingoglia, Barbara Sue Graves · 2025 · Strength and conditioning journal
  12. Treatment Responsiveness of Motor Features in Parkinson's Disease: A Matched Case‐Control Analysis
    Angus D. Macleod, Carl E Counsell · 2019 · Movement Disorders Clinical Practice
  13. Non-motor symptoms related to quality of life and dependency in Parkinson patients at San Pedro de Alcántara Hospital: Differences between men and women
    Adela Gómez-Luque, Mario Holguín-Mohedas, Ana Teresa Domínguez-Martín, Isabel Panea-Pizarro, Sara Huerta González, André Novo, Leonel São Romão Preto, Fidel López‐Espuela · 2021 · Revista Científica de la Sociedad de Enfermería Neurológica (English ed )
  14. Primary care for people with Parkinson's disease in Brazil: A referral flowchart based on risk of falls
    Rafaela Simon Myra, Micheline Henrique Araújo da Luz Koerich, Elaine Cristina Gregório, Alessandra Swarowsky · 2022 · Frontiers in Public Health
  15. Quivering hand and heart: Parkinson's disease is not associated with increased in-hospital mortality in atrial fibrillation hospitalizations: A nationwide analysis
    Emmanuel Uchechukwu Ukenenye, Tolulope Oshiba, Emeka Okoronkwo, Elvis Obomanu, Gideon Asaolu, Alexsandra Urhi, Iyanu Victoria Olateju, Henry Onyemarim, Consolata I. Uzzi, Gabriel Alugba et al. · 2023 · Heliyon
  16. Cognitive–Behavioral Treatment for Anxiety and Depression in Parkinson’s Disease
    Gretchen Reynolds, Ryan J. Piers, Alice Cronin‐Golomb · 2023
  17. Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system
    Petra Marešová, Lukas Rezny, Petr Bauer, Marián Valko, Kamil Kuča · 2024 · BMC Public Health
  18. Impact of Parkinson's disease diagnosis validity on the association with cancer: A systematic review and meta-analysis
    Ayla Mehdiyeva, Valtteri Kaasinen, Eetu Heervä, Jussi Sipilä · 2025 · Parkinsonism & Related Disorders
  19. Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson’s Disease: A Real-World Study
    Yael Barer, Olga Sánchez‐Soliño, Gabriel Chodick, Meital Grabarnik‐John, Shiran Naftelberg Blonder, Neta li Feurestein-Ganor, Lars Bergmann, Connie H. Yan, Sivan Gazit, David Arkadir · 2024 · Advances in Therapy
  20. Mortality and causes of death in patients with Parkinson's disease in Taiwan
    Shang‐Jyh Chiou, Ya‐Hui Hu, Yun-Chung Chen, Da-ling Wang, Alexis Elbaz, Pei‐Chen Lee · 2025 · Journal of Parkinson s Disease
  21. Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson’s disease: a 12-year longitudinal study
    Kyoungwon Baik, Minwoong Kang, Yu Jeong Park, Su Jin Chung, Kyungmi Oh, Sung Hoon Kang, Seong‐Beom Koh · 2025 · Frontiers in Aging Neuroscience
  22. In vitro derivation of midbrain dopaminergic neurons from porcine embryonic stem cells in multi-dimensional conditions
    Hyerin Choi, Dongjin Oh, Ali Jawad, Zheng Haomiao, Jaehyung Ham, Juyoung Heo, Aram Oh, Huijin Jin, Jaehyeok Seo, Byoung Chol Oh et al. · 2025 · Stem Cell Research & Therapy
  23. The influence of beta-amyloid and tau proteins on cognitive changes in Parkinson's disease
    Berit Abraham, Sophia Carl, Lan Ye, Florian Wegner, Matthias Höllerhage, Martin Schulze Westhoff, Felix F. Konen, Ishana V Schneidereit, Thomas Skripuletz, Martin Klietz · 2026 · Parkinsonism & Related Disorders
  24. Survival in Korean Patients with Frontotemporal Dementia Syndrome: Association with Behavioral Features and Parkinsonism
    Na‐Yeon Jung, Kee Hyung Park, Sang Won Seo, Hee Jin Kim, Jee Hoon Roh, Jae‐Hong Lee, Kyung Won Park, Jay Cheol Kwon, Jee Hyang Jeong, Soo Jin Yoon et al. · 2022 · Journal of Clinical Medicine
  25. Classification of long-term clinical course of Parkinson’s disease using clustering algorithms on social support registry database
    Dougho Park, Su Yun Lee, Jong Hun Kim, Hyoung Seop Kim · 2023 · Journal Of Big Data
  26. Identifying Parkinson's Patients by a Functional Gradient Boosting Approach
    Shweta Sharma, Muskan Gupta, Kanu Goyal, Manu Goyal, Parul Sharma · 2024 · Advances in medical technologies and clinical practice book series
  27. Health Service Improvement for People with Parkinson’s Disease: A Scoping Review
    Susan Schneider Williams, Sarah Jane Prior · 2024 · Journal of Ageing and Longevity
  28. Psychometric properties of Arabic-translated-related quality of life scales for people with parkinson disease: a scoping review
    Chiraz Azaiez, Naser Chalghaf, Amayra Tannoubi, Noomen Guelmami, Medina Srem‐Sai, Frank Quansah, John Elvis Hagan, Heifa Sneni, Ghada Boussayala, Imane Ghalmi et al. · 2024 · BMC Public Health
  29. Protecting Parkinson's Patients: Hospital Care Standards to Avoid Preventable Harm
    Peter Pronovost, Hooman Azmi, Michael S. Okun, Benjamin L. Walter, Annie A. Brooks, Sheera Rosenfeld · 2024 · The Joint Commission Journal on Quality and Patient Safety
  30. Incidence, prevalence and mortality of Parkinson’s disease in Greece
    George Makris, Evangelia Samoli, GREGORY I. CHLOUVERAKIS, Cleanthe Spanaki · 2025 · Neurological Sciences
  31. Pharmacological treatment of palliative care patients with Parkinson’s disease
    Zbigniew Żylicz · 2022 · Palliative Medicine in Practice
  32. Computer keyboard interaction as an indicator of early Parkinson’s disease
    Paloma Montero, Michele Matarazzo, Jose Angel Obeso, Raúl San Jośe Estépar, Luca Giancardo, Álvaro Sánchez‐Ferro, Teresa Arroyo‐Gallego, I. Butterworth, Carlos S. Mendoza, Martha L. Gray · 2016 · DSpace@MIT (Massachusetts Institute of Technology)
  33. Africa region: Nigeria
    Morenikeji Adeyoyin Komolafe, Kayode P. Ayodele, Matthew O.B. Olaogun, Philip Ogunbona, Bimbo Fawale, Abiola Oladele Ogundele, Akintunde Adebowale, Oluwasegun T. Akinniyi, Sunday O. Ayenowowan, Abimbola M. Jubril et al. · 2023 · Elsevier eBooks
  34. Is the timed up and go (TUG) sensitive to differentiating patients with mild to moderate PD compared to age matched controls: a descriptive pilot study
    Nancy Nies Byl, Henry R, Rizzo R, D Blum · 2018 · International Physical Medicine & Rehabilitation Journal
  35. Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?
    Isabell Katharina Rumrich, Valtteri Kaasinen, Otto Hänninen, Sirpa A. Hartikainen, Anna‐Maija Tolppanen · 2023 · Environment International
  36. Progression in Parkinson's Disease
    Krithi Irmady, Serge Przedborski · 2025 · Cold Spring Harbor Perspectives in Medicine
  37. Determining sample sizes for combined incident and prevalent cohort studies with and without follow-up
    James H. McVittie · 2024 · Statistical Methods & Applications
  38. Mortality in elderly Parkinson's disease patients with long-term care needs: A nationwide population-based study in Korea
    Seung Hyun Lee, Mina Kim, Woon Chang Heo, Joong‐Goo Kim, Jung Seok Lee, Ji Hoon Kang, Jooyoung Lee · 2024 · Parkinsonism & Related Disorders
  39. Tendência temporal da mortalidade por doença de Parkinson em pessoas idosas no Brasil, 2002-2021
    Thamara Hübler Figueiró, Viviane Nogueira de Zorzi, Eleonora d’Orsi, Cassiano Ricardo Rech, Danúbia Hillesheim · 2024 · Epidemiologia e Serviços de Saúde
  40. The APOE ε4 allele affects the survival of patients with Parkinson's disease independent of dementia
    Zheng Wang, Li Lu, Qian Xu, Hongxu Pan, Yijing Wang, Long Qin, Yuanfeng Huang, Yinghong Dai, Shiyu Zhang, Qiao Zhou et al. · 2025 · Journal of Translational Medicine
  41. Neuroprotective mechanisms of sodium butyrate in Parkinson’s disease in preclinical rodent models: a systematic review and meta-analysis
    Leila Hosseini, Azizeh Farshbaf‐Khalili, Arezoo Moini Jazani, Leila Maghsoumi‐Norouzabad · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  42. Real-world analysis and future trends of parkinson's disease burden and all-cause mortality in Shanghai Pudong: a population-based study of 3.17 million people
    Zheng Luo, Jie Xue, Yan Zhang, Yi‐Chen Chen, Aiqing Fan, Ru Liu, Wenchang Jia, Xiaoling Wu, Qizhe Wang, Huihui Lv et al. · 2025 · BMC Public Health
  43. The impact of depressive symptoms on 5-year all-cause mortality in patients with parkinson’s disease treated with and without deep brain stimulation
    Sarah Marschoun, Marco Treven, Christoph Brücke, Johann P. Lehrner · 2026 · Journal of Neural Transmission
  44. Mapping the Parkinson's pandemic: Unveiling and addressing the global burden
    Ali Shalash, Artur Francisco Schumacher Schuh, Mohamed Salama, Alastair John Noyce, Uyen Ngoc Le Ha, Louis Chew Seng Tan, Caroline M. Tanner · 2026 · Journal of Parkinson s Disease
  45. Mortality rate, main causes of death and factors associated with higher mortality hazard in late stage Parkinson's disease
    Kristina Rosqvist · 2026 · Journal of Parkinson s Disease
  46. Saper desistere per curare fino in fondo: come intraprendere il migliore percorso di assistenza nel Paziente con grave insufficienza d’organo in Medicina Interna?
    F. Zulian, M. Campanini, Luigi Lusiani, Lorenzo Magnani, G. Pinna, Roberto Nardi · 2017 · Italian Journal of Medicine
  47. Reasons for Hospitalization and Factors of Mortality in Patients With Parkinson’s Disease in the Philippines
    Adrian Isidoro Espiritu, Ma. Margarita Anna C Brillantes, Allister Vincent G Layog, Roland Dominic G. Jamora · 2021 · Neurodegenerative Disease Management
  48. Neues zu Diagnostik und Therapie des idiopathischen Parkinson-Syndroms
    Eva Wiegand, Lars Timmermann, David José Pedrosa · 2022 · Neurologie up2date
  49. Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis
    Stuart Isaacson, Rajesh Pahwa, Fernando Pagán, Victor Abler, Daniel Dung Truong · 2024 · Clinical Parkinsonism & Related Disorders
  50. Study of cognitive impairment and genetic polymorphism of SLC41A1 (rs11240569 allele) in Parkinson’s disease in Upper Egypt: case-control study
    Hamdy N. El-Tallawy, Tahia Hashim Saleem, Wafaa M. A. Farghaly, Heba M. Saad Eldien, Ashraf Khodaery, Sherif A. Sayed, Ahmed A. Helaly, Hassan Mohammed Elnady · 2021 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
  51. Movement Disorders in Migrants
    Mounia Rahmani · 2021 · Sustainable development goals series
  52. Doesn't subthalamic nucleus deep brain stimulation have a neuroprotective effect in Parkinson's disease patients?
    Y.-C. Chen, Guanyu Zhu, Lin Shi, Anchao Yang, X. Wang, Jianhang Zhang, Yin Jiang, Xing‐Ding Zhang · 2017 · Acta Neurologica Scandinavica
  53. Reply to Rumrich and colleagues (What does “Parkinson’s disease mortality” mean?)
    Tom Cole‐Hunter, Jiawei Zhang, Youn‐Hee Lim, Evangelia Samoli, Jie Chen, Maciej Strak, Kathrin Wolf, Gudrun Weinmayr, Emanuel Zitt, Barbara H. Hoffmann et al. · 2023 · Environment International
  54. Parkinson's disease inpatient mortality: Attention to sudden death
    Tomás de la Rosa, Fulvio Alexandre Scorza · 2024 · Clinics
  55. Cortical connectivity predicts cognition across time in Parkinson’s disease
    Hunter P Twedt, Brooke E. Yeager, Jacob E. Simmering, Jordan L. Schultz, Nandakumar S. Narayanan · 2025 · medRxiv
  56. Linear predictive coding electroencephalography algorithms predict Parkinson’s disease mortality using out-of-sample tests
    Simin Jamshidi, Arturo I. Espinoza, Jonathan T. Heinzman, Patrick May, Ergun Y. Uc, Nandakumar S. Narayanan, Soura Dasgupta · 2025 · medRxiv
  57. Modifications of cortical activity by deep brain stimulation in advanced Parkinson's disease: an MEG study
    Katja Airaksinen · 2015 · Työväentutkimus Vuosikirja
  58. Hospice Dementia Care
    Richard E. Powers, Heather Herrington · 2015 · Springer eBooks
  59. Sterbewunsch bei der Parkinson-Krankheit
    Peter Franz · 2015 · NeuroTransmitter
  60. Optimizing Care for Older Adults With Dementia-Associated Psychosis
    Cynthia L. Blevins · 2018 · The Journal for Nurse Practitioners
  61. Response to the letter by Scorza et al
    Liis Kadastik‐Eerme, Nele Taba, T Asser, Pille Taba · 2018 · Acta Neurologica Scandinavica
  62. Indications for Deep Brain Stimulation Therapy in Parkinson’s Disease
    Andrea Archambault Brock, Melissa Hardy, Paul A. House · 2018 · Springer eBooks
  63. The biology of cognitive decline and reduced survival in Parkinson disease : prognostic factors in a population-based cohort
    David C. Bäckström · 2019 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  64. Neue Studien zu Parkinson
    Stephan Klebe · 2019 · DNP - Der Neurologe und Psychiater
  65. Remote-Messung bei idiopathischem Parkinson-Syndrom: Entwicklungen in Diagnose, Monitoring und Therapie
    Urs Kleinholdermann, Johannes Werner Melsbach, David José Pedrosa · 2019 · Der Nervenarzt
  66. Efeitos do método pilates na funcionalidade e qualidade de vida na doença de Parkinson
    Lydiane Kellen Benneterre de Araújo, Leilane da Fonseca de Oliveira Silva, Larissa Natsumi Hosoda Mineshita, Marlyce Brasil Lopes, Bento Edgar de Almeida Crisostomo, Larissa Salgado de Oliveira Rocha, Elysson Raul Ferreira Batista, Ana Júlia Cunha Brito, Mariana dos Anjos Furtado de Sá, Dayse Danielle de Oliveira Silva · 2020 · Revista Eletrônica Acervo Saúde
  67. Prognostication and Goals of Care in Advanced Parkinson’s Disease
    Kevin McGehrin, Christina L. Vaughan · 2020 · Springer eBooks
  68. Progression of motor symptoms in Parkinson's disease
    Daniela Vieira, Joana Jesus‐Ribeiro, Cristina Januário · 2020 · Elsevier eBooks
  69. Swallowing impairment in Parkinson's disease
    Maira Rozenfeld Olchik, Marina Padovani, A. Jean Ayres · 2020 · Elsevier eBooks
  70. Síntomas no motores relacionados con calidad de vida y dependencia en pacientes con Parkinson del Hospital San Pedro de Alcántara: diferencias entre hombres y mujeres
    Adela Gómez-Luque, Mario Holguín-Mohedas, Ana Teresa Domínguez-Martín, Isabel Panea-Pizarro, Sara Huerta González, André Novo, Leonel São Romão Preto, Fidel López‐Espuela · 2020 · Revista Científica de la Sociedad Española de Enfermería Neurológica
  71. Comparação dos efeitos da estimulação cerebral profunda do núcleo subtalâmico versus globo pálido interno sobre os sintomas não motores da doença de Parkinson e sua correlação com
    Maria Gabriela dos Santos Ghilardi · 2020
  72. Swallowing impairment in Parkinson's disease
    Maira Rozenfeld Olchik, Marina Padovani, A. Jean Ayres · 2020 · Elsevier eBooks
  73. Syndromes parkinsoniens
    Philippe Couratier · 2022 · Elsevier eBooks
  74. Epidemiology
    Roger L. Albin · 2022 · Oxford University Press eBooks
  75. Detecting Parkinson's Disease
    2022
  76. Foslevodopa-Foscarbidopa (Vyalev)
    CADTH · 2023 · Canadian Journal of Health Technologies
  77. Estudo prospectivo aleatorizado para avaliar a eficácia e a segurança da estimulação magnética da medula espinhal na dor nociceptiva em pacientes com doença de Parkinson
    Jorge Dornellys da Silva Lapa · 2023
  78. A Comprehensive Review of the Neuroprotective Effects of Saffron (Crocus Sativus) and its Constituents in Parkinson's Disease
    Alireza Hoseini, Amirhossein Heidari, Ali Shoeibi, Sahar Fanoudi · 2023 · SSRN Electronic Journal
  79. Refining the Diagnostic Accuracy of Parkinsonian Disorders using Metaphenomic Annotation of the Clinicopathological Literature
    Quin Massey, Leonidas Nihoyannopoulos, Peter Zeidman, Thomas T. Warner, Kailash P. Bhatia, Sonia Gandhi, Christian Lambert · 2023 · medRxiv
  80. Constructing Parkinson's disease progression- endotype molecular networks for drug repurposing: multi-omics evidence aggregation and large-scale real-world data validation
    Manqi Zhou, Alison Ke, Zhenxing Xu, Zhengkang Fan, Kun Chen, Jie Xu, Roberta Marongiu, Fei Wang, Chang Su · 2024 · medRxiv
  81. Histone Acetylation Contributes to Mitochondrial Dysfunction and Neuroinflammation in Parkinson's disease
    Minhong Huang · 2022
  82. A função cognitiva na Doença de Parkinson: uma revisão integrativa
    Camila Marchiori Pereira, Renata Massalai · 2024 · Revista Neurociências
  83. Refining the Diagnostic Accuracy of Parkinsonian Disorders Using Metaphenomic Annotation of the Clinicopathological Literature
    Quin Massey, Leonidas Nihoyannopoulos, Peter Zeidman, Thomas T. Warner, Kailash P. Bhatia, Sonia Gandhi, Christian Lambert · 2024 · SSRN Electronic Journal
  84. Umfassende Versorgung bis zuletzt
    Anna J. Pedrosa Carrasco, David José Pedrosa · 2024 · Nervenheilkunde
  85. MORTALIDADE POR DOENÇA DE PARKINSON E COMERCIALIZAÇÃO DE AGROTÓXICOS NO ESTADO DO PARANÁ
    Paula Renata Olegini Vasconcellos, Maria Lúcia Frizon Rizzotto, Marcelo Taglietti · 2024 · Hygeia - Revista Brasileira de Geografia Médica e da Saúde
  86. Noninvasive Therapies: A Forthcoming Approach to Parkinson's Treatment
    Umer Anayyat, Faiza Ahad, Bushra Muhammad Fordil, Hajra Hameed, Mengqing Li, Qinyao Yu, Yunpeng Wei, Xiaomei Wang · 2024 · CNS & Neurological Disorders - Drug Targets
  87. Andrographolide and its Structural Analogs in Parkinson’s Disease
    Ravilla Jyothsna Naidu, Juturu Mastanaiah, Sasikala Chinnappan, Hemanth Kumar, Alagusundaram Muthumanickam, Goli Venkateswarlu, Arijit Chaudhuri, Vinod Kumar Nelson · 2024 · BENTHAM SCIENCE PUBLISHERS eBooks
  88. Survival of Patients at a Neurology Clinic
    Kyle Steenland, Youran Tan, Shirley M. Mullins, Taylor E. Kidd, Qiyun Gong, James J. Lah · 2025 · Alzheimer Disease & Associated Disorders
  89. Intranasal administration of isradipine preferentially targets the brain
    Jaime N. Guzmán, Ema IIijic, Jack T Nguyen, Dalton James Surmeier · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  90. MỘT SỐ YẾU TỐ LIÊN QUAN VỚI HỘI CHỨNG DỄ BỊ TỔN THƯƠNG Ở NGƯỜI BỆNH PARKINSON
    Lực Trần Viết, Hương Nguyễn Thị Thu, Đạt Nguyễn Quốc, Anh Nguyễn Trung · 2025 · Tạp chí Y học Việt Nam
  91. Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson’s disease: A longitudinal study
    Kyoungwon Baik, Minwoong Kang, Yu Jeong Park, Su Jin Chung, Kyungmi Oh, Sung Hoon Kang, Seong‐Beom Koh · 2025 · Research Square
  92. Secular Trends and Survival of Parkinson's Disease and Other Forms of Parkinsonism in the United Kingdom
    Sacha E. Gandhi, Katherine A. Grosset, Prasanth A. Iruthayaraj, Romel Gravesande, Lance Lee, Cathal Doyle, Yoav Ben‐Shlomo, Donald G. Grosset · 2025 · SSRN Electronic Journal
  93. Estimation of Survival with Parkinson’s disease in the Canadian Longitudinal Study on Aging: An analysis using only current disease durations observed at baseline
    James H. McVittie, David B. Wolfson, Ronald B. Postuma, Christina M. Wolfson · 2025 · medRxiv
  94. Épidémiologie
    Virginie Chrysostome, François Tison · 2020 · Elsevier eBooks
  95. 67/m mit Bewegungseinschränkungen
    Lea Roddewig, Sandra Burmester, Eva Hummers · 2025 · Zeitschrift für Allgemeinmedizin
  96. Introduction of a smartwatch-based Parkinson's management in Germany: Health economic considerations from a payer perspective
    Florian Brandt, Giancarlo Simone, Christian Krey, Patty Lee, Sergiu Groppa · 2025 · International Journal of Healthcare Management
  97. Decoding human lifespan from neural noise and explaining age-related changes in fractal dimension and gamma oscillations using fractional harmonic oscillator
    Srishty Aggarwal · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Survival after Subthalamic Deep Brain Stimulation for Parkinson's Disease: 25‐Year Experience from a Single Center
    Sayooja Sachithanandan, Athul Sreelatha Sanjeev, Jissa Vinoda Thulaseedharan, Krishnakumar Kesavapisharady, Divya Kalikavil Puthanveedu, Asish Vijayaraghavan, Gangadhara Sarma, Syam Krishnan, Asha Kishore · 2025 · Movement Disorders Clinical Practice
  99. Impact of dipeptidyl peptidase 4 inhibitor use on mortality in diabetic Parkinson's disease patients: A nationwide cohort study
    Mincheol Park, Ho Kyung Lee, Yeonju Jin, Sanghee Yoo, Sung-Woo Kim, Sojeong Park, Jiwon Hong, Jin Yong Hong, Ickpyo Hong, Min Seok Baek · 2025 · Parkinsonism & Related Disorders
  100. Cortical connectivity is associated with cognition across time in Parkinson's disease
    Hunter P Twedt, Brooke E. Yeager, Jacob E. Simmering, Jordan L. Schultz, Nandakumar Narayanan · 2025 · Neuroimage Reports